Deva Holding A.S. (DEVA.IS) Stock Analysis & Winston Score

Deva Holding A.Ş. is a Turkish pharmaceutical company that makes and sells generic and branded medicines. Its products cover a wide range of treatments, including cardiovascular, anti-infective, and central nervous system drugs, sold mainly to hospitals, pharmacies, and healthcare institutions across Turkey. It is one of the larger domestic drug manufacturers in Turkey and operates within a heavily regulated healthcare market. The company earns revenue primarily through product sales of finished medicines, both under its own brands and as generics. Deva operates mainly in Turkey, though it also exports to select international markets. Its competitive position benefits from established manufacturing infrastructure and local market knowledge, but the low operating margin and negative return on invested capital suggest the business is under meaningful cost pressure. A key risk going forward is Turkey's volatile macroeconomic environment, including currency depreciation, which can raise the cost of imported raw materials and squeeze profitability further.